Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 05, 2025 12:30 ET | Source: AstuteAnalytica India Pvt. Ltd.

Digital Therapeutics Market to Reach US$ 36.47 Billion By 2032 | Astute Analytica

New Delhi, Feb. 05, 2025 (GLOBE NEWSWIRE) -- The global digital therapeutics market valuation is poised to reach US$ 36.47 billion by 2032, with a CAGR of 23.0% during the forecast period from 2024...
February 05, 2025 10:42 ET | Source: Transparency Market Research

On-Body Drug Delivery Devices Market Hits US$ 390.7 Million in 2023, Set to Reach US$ 796.1 Million by 2034 with a 6.8% CAGR | TMR Research

Wilmington, Delaware, Transparency Market Research Inc. – , Feb. 05, 2025 (GLOBE NEWSWIRE) -- The global on-body drug delivery devices market is revolutionizing patient care by enabling painless,...
January 31, 2025 09:45 ET | Source: Transparency Market Research

Non-Muscle Invasive Bladder Cancer Market Poised for $21.1 Bn Surge by 2034, Driven by Expanding Therapeutic Innovations | Transparency Market Research

Wilmington, Delaware, Transparency Market Research Inc. –, Jan. 31, 2025 (GLOBE NEWSWIRE) -- The global non-muscle invasive bladder cancer (NMIBC) market (非筋肉浸潤性膀胱癌市場), valued at US$ 2.6 billion in...
January 30, 2025 10:00 ET | Source: SNS Insider pvt ltd

Organic Chemicals Market Projected to Reach USD 24.25 Billion by 2032 | Rising Adoption in Key Industries and Increasing Demand for Sustainable Solutions Fuel Market Growth

Austin, Jan. 30, 2025 (GLOBE NEWSWIRE) -- As per the latest research report of SNS Insider, “The Organic Chemicals Market is projected to reach a valuation of USD 24.25 billion by 2032, growing at a...
January 30, 2025 09:45 ET | Source: SNS Insider pvt ltd

Veterinary Therapeutics Market Size to Hit USD 82.40 Billion by 2032, Growing at a CAGR of 7.35% - SNS Insider

Pune, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Veterinary Therapeutics Market Size & Growth Analysis: “According to SNS Insider, The Veterinary Therapeutics Market size was valued at USD 43.58 Billion...
January 29, 2025 08:30 ET | Source: Rakovina Therapeutics Inc

Rakovina Therapeutics to Participate in BioInnovate UBC Annual Conference

VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer therapies through artificial...
January 28, 2025 12:07 ET | Source: Research and Markets

Gene Delivery Systems Market Research 2024 with Forecasts to 2030: Surge in Research Funding for Developing Novel Gene Delivery Methods, Expansion of Clinical Trials for Neurological Disorders

Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Gene Delivery Systems - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Gene...
January 28, 2025 08:38 ET | Source: Research and Markets

Biologics Market Research Report 2024-2030: Technological Innovations in Monoclonal Antibodies and Gene Therapies Fueling Developments and Growth

Dublin, Jan. 28, 2025 (GLOBE NEWSWIRE) -- The "Biologics - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Biologics was estimated...
January 23, 2025 11:30 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd.

Global Cytotoxic Drugs Market Poised for Significant Growth Driven by Rising Cancer Prevalence and Advancements in Oncology Therapies | FMI

NEWARK, Del, Jan. 23, 2025 (GLOBE NEWSWIRE) -- The global cytotoxic drugs market is projected to generate USD 17,753.7 million in sales by 2025, with an estimated growth to USD 29,169.1 million by...
January 23, 2025 08:00 ET | Source: ALX Oncology

ALX Oncology Presents Positive Updated Data from ASPEN-06 Phase 2 Trial Demonstrating Evorpacept Generates Strong Response and Durable Clinical Benefit in Patients with HER2-Positive Gastric Cancer

Oral presentation at 2025 ASCO Gastrointestinal Cancers Symposium today highlights evorpacept as the first CD47 blocker to show substantial tumor response and a well-tolerated safety profile in a...